← Back to Search

Behavioural Intervention

Participants receiving A-CHESS for Alcoholic Liver Disease

Waitlist Available
Led By Robert S Brown, MD, MPH
Research Sponsored by New York Presbyterian Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights


This trial is testing if a smartphone app can help decrease alcohol relapse rates for people with alcoholic liver disease.

Eligible Conditions
  • Alcoholic Liver Disease


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rates of recidivism
Secondary outcome measures
Use of A-CHESS

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants receiving A-CHESSExperimental Treatment1 Intervention
Participants will be provided access to the smartphone application A-CHESS (intervention) that will be downloaded to their phone.
First Studied
Drug Approval Stage
How many patients have taken this drug

Find a Location

Who is running the clinical trial?

New York Presbyterian HospitalLead Sponsor
74 Previous Clinical Trials
49,190 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,198 Previous Clinical Trials
3,162,234 Total Patients Enrolled
Robert S Brown, MD, MPHPrincipal InvestigatorWeill Cornell Medical College/NYPH
3 Previous Clinical Trials
633 Total Patients Enrolled
~4 spots leftby Jul 2025